newsfilter
← Latest News
GlobeNewswire·

Homology Medicines to Present at Upcoming Conferences on its Gene Editing and Gene Therapy Programs for PKU

BEDFORD, Mass., June 29, 2022 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (NASDAQ:FIXX), a genetic medicines company, announced today participation and presentations at the following conferences: FASEB's The Genome Engineering Conference: Cutting-E